Jordanian Sboul: I worked as 20-years volunteer before becoming USP President
Ammon News - Dr. Hanan Sboul expressed her pride and happiness at being elected as President of the United States Pharmacopoeia (USP) for a five-year term, an achievement that is considered the first of its kind in the world, as she became the first Jordanian woman and the first non-American to hold this position since the constitution was established in 1820.
In remarks to "Ammon News Agency", Sboul said that her election is the culmination of more than 20 years of volunteer work serving the pharmaceutical sector globally, with the goal of empowering the Jordanian pharmaceutical industry and enhancing Jordan's standing and presence in scientific and international forums. She emphasized that this position is a continuation of a long journey of effort and perseverance.
She expressed her pride in being the first Jordanian woman to reach this leadership position, noting that she had been the only Arab woman on the Constitutional Council for two decades, during which she had worked to bring a number of Arab countries on board as members, thereby strengthening Arab presence within the institution.
In an unparalleled global accomplishment, Sboul, the secretary-general of the Jordanian Association of Pharmaceutical Manufacturers, was chosen president of the United States Pharmacopeia (USP) for a five-year term.
More than 400 members from 42 countries attended a meeting last week in the United States, where they represented regulatory authorities, pharmaceutical companies, medical and pharmacy schools, and associations of doctors and pharmacists.
Since the USP's establishment in 1820, Sboul has been the first elected foreign president and the first woman to hold the office. This momentous occasion demonstrates her illustrious standing in the fields of medicine and public health and demonstrates the faith of the global scientific community in her scientific proficiency.
It is important to note that the main source for creating drug standards and specifications is the US Pharmacopoeia. It is utilized in more than 150 countries and is widely acknowledged for guaranteeing the efficacy, safety, and quality of pharmaceuticals. This accomplishment highlights the innovative position of Jordanian capabilities on the Arab and global stages and is a source of pride for the pharmaceutical and medical communities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Ammon
3 days ago
- Ammon
Jordanian female pilgrim dies due to natural causes
Ammon News - A Jordanian pilgrim in her seventies died early dawn Thursday in Mount Arafat from natural causes, according to Ali Daqamseh, the Ministry of Awqaf and Islamic Affairs' official spokesperson. The deceased pilgrim, Arifa Mustafa Al-Nahar Abu Al-Assad, had pre-existing illnesses Daqamseh said.
Ammon
4 days ago
- Ammon
3.956 million heads of sheep, goats in Jordan by 2024
Ammon News - The total number of sheep and goats in Jordan reached approximately 3.956 million heads in 2024, marking a 1 percent increase compared to 2023, according to the Department of Statistics' Livestock Numbers Report for the Informal Sector released Wednesday. The report indicated that the sheep population grew by 1 percent, rising to 3.076 million heads in 2024, up from 3.049 million in 2023. Meanwhile, the number of goats increased by 4 percent, reaching 880,000 heads compared to 850,000 the previous year. The data also showed a 2 percent rise in livestock births, with a total of 2.376 million newborns in 2024, compared to 2.332 million in 2023. Sales for slaughter from newborn livestock saw a 1 percent increase, with 31.5 percent of the total being sold for this purpose. The number of animals slaughtered rose significantly to 1.227 million in 2024, up from 932,000 in 2023.
Ammon
4 days ago
- Ammon
New rare wild orchid seen in UK for first time in 100 years
Ammon News - A new lady's-slipper orchid, once believed to be extinct in the UK, has been spotted in the wild for the first time in 100 years following a decades-long conservation drive, experts said Tuesday. Over-picking by Victorian collectors, gripped by the orchid craze of the time, was thought to have made the yellow cup-shaped and purple-petalled plant extinct by the early 1900s. But a single plant was discovered in a remote location in the Yorkshire Dales in northern England in 1930. Its location was kept secret and volunteers have since provided round-the-clock monitoring to prevent it from being stolen. Last summer, Yorkshire Wildlife Trust supported by various conservation groups discovered the first new lady's-slipper orchid to appear in the wild since then, it said Tuesday. It is the culmination of a decades-long bid to bring back the flower, and has sparked hopes that it could one day be restored across its former range in northern England. Yorkshire Wildlife Trust secured a grant from Natural England's species recovery programme two years ago to protect the habitat, rearing many new orchids and reintroducing plants into suitable terrains. The new plant was spotted at one of the reintroduction sites, meaning planted-out orchids had produced seeds that had germinated into new plants. Jono Leadley, managing the project on behalf of Yorkshire Wildlife Trust, called it a "truly thrilling moment". "To see a healthy population of lady's-slipper orchids back in their native area that are now reproducing themselves gives us real hope for the future," he said. The orchids were propagated by London's Royal Botanical Gardens in Kew, after a call for help was issued in the 1990s. That led to a small number of privately-owned, wild-sourced orchids being offered as part of a breeding programme. "Trying to save the lady's slipper orchid in England has been one of RBG Kew's flagship conservation projects for many years," said RBG Kew's senior research leader Mike Fay.
